Industry Insights
Stripping Membranes For Reprobing
Article | GE Healthcare Life Sciences

Detect more than one protein by chemiluminescence on the same Western blot membrane by stripping and reprobing the membrane with a different primary antibody.

Anticipating The Formulation Challenges Of Complex Molecules
Article | Thermo Fisher Scientific

Due to the increasing complexity of today’s API molecules, formulation problems are arising with greater frequency, delaying development, and burdening developers with unanticipated and heavy costs.

Pharmacokinetic Strategies In CNS Drug Discovery
White Paper | GVK Biosciences

The failure rate for new drugs targeting important CNS diseases in general have higher failure rates than the other diseases, both preclinically and clinically. Pharmacokinetics of the drug along with the drug delivery mechanisms play an important role in determining the success of new CNS drug because blood-brain barriers (BBB) limit the entry of molecules into the CNS. This paper discusses some successful PK approaches that we have employed in the recent past and may help in CNS targeted drug discovery and development efforts.

5 Reasons External Collaborations Fail In Drug Discovery
White Paper | Dassault Systemes Americas

This white paper, brought to you by Dassault Systèmes BIOVIA, discusses the different types of external collaborations research organizations engage in, the reasons that many of these partnerships fail to meet expectations, and an informatics solutions to overcome these issues.

Now & Next: Mavupharma
Q&A | Jubilant Biosys

Saurabh Kapure, Vice President, Business Development, USA for Jubilant Biosys, recently sat down with Michael Gallatin, Ph.D., president and co-founder of Mavupharma (Mavu), the drug discovery and development company, to discuss some of the latest developments in the industry and at Mavu. In this Q&A, Dr. Gallatin shares his thoughts about Mavupharma, his role at the company, the evolution of biopharma, drug discovery, development, and the road ahead for the industry with Saurabh.

Designing Complex Release Oral Solids
Infographic | Catalent

Learn how controlled and modified release can provide improved compliance and therapeutic effectiveness with right release profile based on API properties, PK challenges, and patient needs.

ChemiDoc MP Imaging System
Bio-Rad Laboratories, Inc.
GE Healthcare Life Sciences Webinar: Smarter Development Of Chromatography Processes

September 24, 2019 | 11:00 a.m. EDT

Smart process development is a collection of approaches to make process development better and faster — providing the developers with tools to face the rapidly changing landscape. This webinar will review three fields that enable reduced timelines and improved outcomes of process development activities:

  • In-silico process development and data-driven decisions
  • Management of process variability through deeper process understanding
  • Use of high-throughput methodologies
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.